Sociodemographic and clinical variables as determinants of mortality and survival in patients with acute ST-elevation myocardial infarction in the Eastern Amazon
- PMID: 36686587
- PMCID: PMC9846297
- DOI: 10.1177/22799036221150062
Sociodemographic and clinical variables as determinants of mortality and survival in patients with acute ST-elevation myocardial infarction in the Eastern Amazon
Abstract
Background: The aim of this study was to analyze the influence of sociodemographic and clinical variables as determinants of mortality and survival in patients with ST-segment elevation acute myocardial infarction in the Eastern Amazon.
Design and methods: This observational, longitudinal, and retrospective study was conducted at the Gaspar Vianna Clinical Hospital Foundation in patients hospitalized from January 2017 to June 2020. Patients were divided into two groups: those who survived (G1) (n = 646) and those who died (G2) (n = 37). Sociodemographic and clinical variables associated with mortality and survival in these two groups were analyzed.
Results: Patients with STEMI who had the highest risk of death were often the oldest (G1: 61.58 ± 10.74 years; G2: 69.57 ± 9.02 years; t = -4.492; p = 0.001), with Killip III-IV classifications (OR = 0.13; 95% CI = 0.02-0.71; p = 0.03), and with diseases such as heart failure (OR = 0.07; 95% CI = 0.004-1.50; p = 0.168) or renal failure (OR = 0.03; 95% CI = 0.006-0.16; p = 0.0001). In addition, female sex (hazard ratio = 2.073; 95% CI = 1.413-5.170), Killip III-IV classifications (hazard ratio = 4.041; 95% CI = 1.703-18.883) and the presence of heart failure (hazard ratio = 34.102; 95% CI = 4.410-263.684) or renal failure (hazard ratio = 14.278; 95% CI = 3.275-62.248) shortened in-hospital survival.
Conclusions: Specific sociodemographic and clinical aspects influenced mortality and survival in patients with acute ST -elevation myocardial infarction.
Keywords: Myocardial infarction; ST elevation myocardial infarction; mortality; survival analysis.
© The Author(s) 2023.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification.JAMA. 2003 Oct 22;290(16):2174-81. doi: 10.1001/jama.290.16.2174. JAMA. 2003. PMID: 14570953
-
Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry.J Am Heart Assoc. 2021 Sep 7;10(17):e017290. doi: 10.1161/JAHA.119.017290. Epub 2021 Sep 1. J Am Heart Assoc. 2021. PMID: 34465127 Free PMC article.
-
Clinical predictors and prognostic role of high Killip class in patients with a first episode of anterior ST-segment elevation acute myocardial infarction.J Cardiovasc Med (Hagerstown). 2021 Jul 1;22(7):530-538. doi: 10.2459/JCM.0000000000001168. J Cardiovasc Med (Hagerstown). 2021. PMID: 34076600
-
Risk factors for in-hospital death in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention: a multicenter retrospective study.Ann Palliat Med. 2021 Nov;10(11):11756-11766. doi: 10.21037/apm-21-2722. Ann Palliat Med. 2021. PMID: 34872300
-
Cardiogenic Shock Among Patients with Acute ST-Segment Elevation Myocardial Infarction in a Middle Eastern Country: A Single-Center Experience.J Saudi Heart Assoc. 2023 Jan 20;34(4):232-240. doi: 10.37616/2212-5043.1323. eCollection 2022. J Saudi Heart Assoc. 2023. PMID: 36816794 Free PMC article.
References
-
- Ibanez B, James S, Agewall S, et al.. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119–177. - PubMed
-
- Levine GN, Bates ER, Bittl JA, et al.. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2016; 134: e123–e155. - PubMed
-
- Massa KHC, Duarte YAO, Chiavegatto Filho ADP. [Analysis of the prevalence of cardiovascular diseases and associated factors among the elderly, 2000-2010]. Cienc Saude Coletiva 2019; 24: 105–114. - PubMed
LinkOut - more resources
Full Text Sources